Multimodal Immune Profiling in Thyroid Eye Disease 2253789

Abstract Introduction Thyroid Eye Disease (TED) is an autoimmune orbital disorder affecting up to half of patients with Graves’ disease. It progresses from inflammation to fibrosis, leading to proptosis, diplopia, and tissue remodeling. While fibroblast diversity is known to influence disease course, the interplay between immune and stromal compartments remains poorly understood. Here, we apply integrated single-cell and TCR sequencing to define cellular programs and immune—stromal interactions across disease stages in TED. Methods Orbital tissue was obtained during decompression surgery from twelve TED patients (active: Clinical Activity Score ≥3, n = 6; inactive: CAS< 3, n = 6) and two non-inflammatory controls. Single-cell RNA and paired V(D)J sequencing characterized cellular heterogeneity and clonality. Differential expression, pathway enrichment, and ligand—receptor interaction analyses were performed to identify mechanisms associated with disease activity and fibrosis. Results Analysis revealed coordinated immune and fibroblast remodeling across disease stages. Active TED was marked by inflammatory—adipogenic PLIN2+/TNFSF8+ fibroblasts, elevated cytokine signaling, and expanded CD8+ T cell clones expressing activation markers (REL, NFKB1, CD69). Inactive TED showed a shift toward fibrotic and contractile fibroblast states (SPARC, GPX3, TAGLN) and reduced T cell clonality. Cross-talk modeling identified a RORA+ fibroblast subset co-expressing TSHR and IGF1R, potentially mediating T cell—fibroblast signaling via ELL2-associated pathways. Conclusion This study provides a multimodal framework linking immune activation with stromal remodeling in TED. By integrating transcriptional and clonotypic data, we uncover immune—stromal circuits that define inflammatory and fibrotic phases, revealing candidate targets for stage-specific intervention. Funding Source Rhodes Scholarship, Canadian Institutes of Health Research (CIHR) Doctoral Foreign Study Award, Kennedy Trust Prize Studentship (KTPS), Wellcome Trust Fellowship Topic Categories Immune Mechanisms of Human Disease (HUM)

Authors

Institutions

Publication Details

Journal
The Journal of Immunology
Published
2026-07-28
DOI
https://doi.org/10.1093/jimmun/vkag141.192
Primary Topic
Ophthalmology and Eye Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multimodal Immune Profiling in Thyroid Eye Disease 2253789

Karène Argoud, Anne Xuan-Lan Nguyen, Joel David, Moustafa Attar et al.
The Journal of Immunology
Ophthalmology and Eye Disorders
article

Multimodal Immune Profiling in Thyroid Eye Disease 2253789

Karène Argoud, Anne Xuan-Lan Nguyen, Joel David, Moustafa Attar, Helen Turner, Rachael Bashford-Rogers, Alexander Clarke, Jonathan Norris, Julia Johnstone, Hana Andrew
article en

Abstract

Abstract Introduction Thyroid Eye Disease (TED) is an autoimmune orbital disorder affecting up to half of patients with Graves’ disease. It progresses from inflammation to fibrosis, leading to proptosis, diplopia, and tissue remodeling. While fibroblast diversity is known to influence disease course, the interplay between immune and stromal compartments remains poorly understood. Here, we apply integrated single-cell and TCR sequencing to define cellular programs and immune—stromal interactions across disease stages in TED. Methods Orbital tissue was obtained during decompression surgery from twelve TED patients (active: Clinical Activity Score ≥3, n = 6; inactive: CAS< 3, n = 6) and two non-inflammatory controls. Single-cell RNA and paired V(D)J sequencing characterized cellular heterogeneity and clonality. Differential expression, pathway enrichment, and ligand—receptor interaction analyses were performed to identify mechanisms associated with disease activity and fibrosis. Results Analysis revealed coordinated immune and fibroblast remodeling across disease stages. Active TED was marked by inflammatory—adipogenic PLIN2+/TNFSF8+ fibroblasts, elevated cytokine signaling, and expanded CD8+ T cell clones expressing activation markers (REL, NFKB1, CD69). Inactive TED showed a shift toward fibrotic and contractile fibroblast states (SPARC, GPX3, TAGLN) and reduced T cell clonality. Cross-talk modeling identified a RORA+ fibroblast subset co-expressing TSHR and IGF1R, potentially mediating T cell—fibroblast signaling via ELL2-associated pathways. Conclusion This study provides a multimodal framework linking immune activation with stromal remodeling in TED. By integrating transcriptional and clonotypic data, we uncover immune—stromal circuits that define inflammatory and fibrotic phases, revealing candidate targets for stage-specific intervention. Funding Source Rhodes Scholarship, Canadian Institutes of Health Research (CIHR) Doctoral Foreign Study Award, Kennedy Trust Prize Studentship (KTPS), Wellcome Trust Fellowship Topic Categories Immune Mechanisms of Human Disease (HUM)

The Journal of ImmunologyVol. 215(Supplement_1)
University of Oxford (GB), Institute of Rheumatology (CZ), Kennedy Center (DK), Oxford Centre for Diabetes, Endocrinology and Metabolism (GB), Oxford University Hospitals NHS Trust (GB)
Openalex Percentile: Top 9%
Ophthalmology and Eye Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.